Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination Therapies for Nonalcoholic Fatty Liver Disease
Evangelia Makri, Eleftheria Makri, Stergios A. Pοlyzos
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1166-1166
Open Access | Times Cited: 36

Showing 26-50 of 36 citing articles:

Inflammation and Lipid Metabolism Relationships on The Example of NAFLD and Atherosclerosis Relationships

Journal of Angiotherapy (2024) Vol. 8, Iss. 5
Open Access
Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, et al.
Cureus (2024)
Open Access
Jolkinolide B Ameliorates Liver Inflammation and Lipogenesis by Regulating JAK/STAT3 Pathway
Hye-Rin Noh, Guo-Yan Sui, Jin Woo Lee, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 6, pp. 793-800
Open Access
Letter: Combination Therapies With Vitamin E for Metabolic Dysfunction‐Associated Steatotic Liver Disease
Stergios A. Pοlyzos, Jannis Kountouras
Alimentary Pharmacology & Therapeutics (2024)
Closed Access
Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet
Evangelia Makri, Konstantinos Xanthopoulos, Spyros Pettas, et al.
HORMONES (2024)
Closed Access
Unravelling the Interplay: Exploring the Influence of Previous Hepatitis B Virus, Hepatitis A Virus, and Hepatitis E Virus Infections on Non-alcoholic Fatty Liver Disease
Vinay Narladkar, Aman Agrawal, Sanket S Bakshi, et al.
Cureus (2023)
Open Access | Times Cited: 1
Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease
Stergios A. Pοlyzos, Gema Frühbeck, Dimitrios N. Kiortsis
Current Pharmaceutical Design (2023) Vol. 29, Iss. 41, pp. 3263-3265
Closed Access | Times Cited: 1
Nonalcoholic Fatty Liver Disease and Helicobacter pylori Infection: Is it Time to Address this Potential Relationship?
Stergios A. Pοlyzos, Jannis Kountouras
Current Vascular Pharmacology (2023) Vol. 21, Iss. 2, pp. 78-80
Closed Access
Personalized treatment of metabolic (dysfunction-)associated fatty liver disease
Jan Clusmann, Kai Markus Schneider, Paul-Henry Koop, et al.
Deleted Journal (2023) Vol. 18, Iss. 4, pp. 300-307
Closed Access
Multifactorial Aspects of Adiponectin in Non- Alcoholic Fatty Liver Disease
Aswathi Rajan, L Karpagavel, Midhun TM, et al.
Journal Of Advanced Zoology (2023) Vol. 44, Iss. 3, pp. 903-930
Open Access
The roles of purple sweet potato anthocyanins in optimizing dietary intervention of metabolic dysfunction-associated fatty liver disease
Syuma Adhy Awan, I Dewa Nyoman Wibawa, I Made Jawi, et al.
Bali Medical Journal (2023) Vol. 12, Iss. 2, pp. 2030-2039
Open Access
Previous Page - Page 2

Scroll to top